InVivo Therapeutics CorpのROCE
InVivo Therapeutics CorpのROCEは何ですか。
InVivo Therapeutics Holdings CorpのROCEは-102.89%です。
ROCEの定義は何ですか。
使用資本利益率(ROCE)は、企業の収益性とその資本が使用される効率を測定する財務比率です。
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
NASDAQのセクタHealth CareにおけるROCEの企業と比べるInVivo Therapeutics Corp
InVivo Therapeutics Corpは何をしますか。
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
InVivo Therapeutics Corpと類似のroce
- Tattooed ChefのROCEは-103.33%です。
- American Eagle GoldのROCEは-103.24%です。
- Calyxt IncのROCEは-103.14%です。
- PLx PharmaのROCEは-103.05%です。
- IntelGenx TechnologiesのROCEは-103.05%です。
- Hempfusion WellnessのROCEは-103.00%です。
- InVivo Therapeutics CorpのROCEは-102.89%です。
- Codrus MineralsのROCEは-102.84%です。
- FibroGen IncのROCEは-102.70%です。
- Kina PetroleumのROCEは-102.59%です。
- ImmunomeのROCEは-102.45%です。
- DynaCERTのROCEは-102.30%です。
- Biofrontera AGのROCEは-102.17%です。